What is the recommended anesthesia approach for a child with patent ductus arteriosus (PDA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthesia Management for Children with Patent Ductus Arteriosus

For children with PDA undergoing surgical ligation or catheter-based procedures, general anesthesia with careful hemodynamic monitoring is the standard approach, prioritizing maintenance of systemic vascular resistance, avoiding increases in pulmonary blood flow, and ensuring adequate ventilation to prevent worsening left-to-right shunting. 1

Pre-Anesthetic Assessment and Planning

Critical Hemodynamic Evaluation

  • Confirm PDA hemodynamic significance through echocardiography with color Doppler in the parasternal short-axis view, measuring the transpulmonary gradient with continuous-wave Doppler to estimate pulmonary artery pressure 2
  • Assess for left atrial and left ventricular enlargement, which indicates significant volume overload requiring careful fluid management 2
  • Evaluate for pulmonary hypertension and determine shunt direction, as this fundamentally alters anesthetic goals 2
  • Consider cardiac catheterization when significant elevation of pulmonary vascular resistance is suspected or echocardiography is non-diagnostic 2

Special Considerations for Premature Infants

  • Very low birth weight (VLBW) infants with PDA require heightened vigilance due to immature ductal muscle, increased risk of intraventricular hemorrhage, and limited physiologic reserves 3, 4
  • Assess renal function before any pharmacologic intervention, as NSAIDs used for medical closure are contraindicated in renal dysfunction 5
  • Evaluate for active bleeding, particularly intracranial or gastrointestinal, which contraindicates NSAID therapy 5

Anesthetic Technique and Drug Selection

Induction and Maintenance Agents

  • For premature neonates, a balanced technique using fentanyl (2-5 mcg/kg), ketamine (0.15-1 mg/kg), atropine (0.01 mg/kg), and muscle relaxation with pancuronium (0.1 mg/kg) provides hemodynamic stability 6, 1
  • Ketamine is particularly advantageous as it maintains systemic vascular resistance while providing analgesia and amnesia 6
  • Avoid volatile anesthetics that cause significant vasodilation and may worsen left-to-right shunting 1

Airway Management

  • Meticulous airway management with endotracheal intubation is mandatory for all PDA procedures, whether surgical or catheter-based 4
  • Secure the endotracheal tube carefully, as dislodgement during the procedure (reported in 1.5% of cases) can be catastrophic in these fragile patients 1
  • Optimize ventilation strategies to avoid hypercarbia (which increases pulmonary vascular resistance) and excessive positive pressure (which may impair venous return) 4

Intraoperative Monitoring and Management

Hemodynamic Goals

  • Maintain systemic vascular resistance to minimize left-to-right shunting through the PDA while ensuring adequate systemic perfusion 1
  • Avoid rapid fluid administration, which may increase left-to-right shunting and result in pulmonary edema, especially in VLBW infants 3
  • Monitor for signs of decreased systemic perfusion (decreased urine output, metabolic acidosis) that may indicate excessive ductal steal 7

Ventilation Strategy

  • Provide supplemental oxygen throughout the procedure to maintain adequate oxygenation 6
  • Adjust ventilation to maintain normocapnia, as hypercapnia increases pulmonary vascular resistance and may worsen right-to-left shunting if present 4
  • Use lung-protective ventilation strategies in premature infants to minimize barotrauma 4

Temperature Management

  • Precise thermoregulation is critical, particularly in premature infants who have limited thermoregulatory capacity and high surface area-to-volume ratios 4
  • Maintain normothermia using warming devices, warmed fluids, and increased ambient temperature 4

Procedure-Specific Considerations

Surgical Ligation (Open or Video-Assisted Thoracoscopic)

  • Bedside ligation in the NICU is feasible and safe when following a standardized anesthesia protocol, avoiding the risks of transporting critically ill neonates 1
  • Position for left thoracotomy with appropriate padding and monitoring access 6, 8
  • Anticipate minimal blood loss but prepare for potential vascular injury requiring rapid transfusion 6
  • Monitor for pneumothorax (occurs in 4.5% of cases), which may require immediate chest tube insertion 1

Catheter-Based Device Closure

  • For older children with suitable anatomy, transcatheter device closure under conscious sedation or general anesthesia is preferred over surgical approaches 2, 4
  • Administer heparin (50-100 U/kg) at the time of device implantation to prevent thrombotic complications 2
  • Procedures may last 3-5 hours, requiring sustained anesthesia or deep sedation with careful monitoring 9
  • For premature infants undergoing transcatheter closure, general anesthesia is typically required due to procedure duration and need for immobility 4

Postoperative Management and Complications

Immediate Post-Procedure Monitoring

  • Anticipate the need for inotropic or vasodilator support in approximately 32% of patients within 6 hours post-ligation 1
  • Monitor for post-ligation cardiac syndrome (≥ Grade III mitral regurgitation with left ventricular dysfunction and hypotension), which occurs in a small percentage of cases 1
  • Assess for recurrent laryngeal nerve injury, manifesting as weak cry or stridor, particularly after surgical ligation 9, 8

Ventilation and Extubation

  • Continue mechanical ventilation postoperatively in premature infants until hemodynamic stability is confirmed 1
  • Wean ventilatory support cautiously, as closure of a large PDA may initially worsen lung compliance due to increased pulmonary blood flow 7

Pain Management

  • Provide adequate analgesia with opioids (fentanyl or morphine) titrated to effect 1
  • Monitor for respiratory depression, particularly in premature infants with immature respiratory control 4

Critical Pitfalls to Avoid

  • Never use NSAIDs (indomethacin, ibuprofen) in the third trimester of pregnancy due to risk of premature ductal closure 3
  • Avoid aggressive fluid resuscitation that may precipitate pulmonary edema from increased left-to-right shunting 3
  • Do not proceed with PDA closure in patients with pulmonary arterial hypertension and net right-to-left shunt (Eisenmenger physiology), as closure is contraindicated 2
  • Be vigilant for endotracheal tube dislodgement during positioning or surgical manipulation 1
  • Recognize that prostaglandin E1 infusion may need to be stopped several hours before ductal stenting procedures to allow the ductus to become somewhat restrictive for stable stent anchoring 9

References

Guideline

Patent Ductus Arteriosus Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Patent Ductus Arteriosus Management in Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ibuprofen Dosing for Patent Ductus Arteriosus (PDA) Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.